# Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

> **NCT04186026** · NA · UNKNOWN · sponsor: **University of Copenhagen** · enrollment: 35 (estimated)

## Conditions studied

- Obesity

## Interventions

- **OTHER:** Saline + saline
- **OTHER:** Neurotensin + saline
- **OTHER:** GLP-1 + saline
- **OTHER:** GLP-1 + Neurotensin

## Key facts

- **NCT ID:** NCT04186026
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2024-06-10
- **Final completion:** 2024-06-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2023-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04186026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04186026, "Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04186026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*